US$ 28.14
compounded ghk cu GHK-Cu Scalp Solution 89030-95-5 GHK-Cu Gly-His-Lys-Cu Copper Tripeptide-1;
Description
There are numerous reputed companies that manufacture this injection with their unique brand name

Once a multi-dose vial is opened, it typically needs to be used within 30 days
Novel cathepsin C inhibitor, BI 1291583, intended for treatment of bronchiectasis: Phase I characterization in healthy volunteers

Uylings, & M

With Rucaparib treatment, PARP1 appears to trend towards decreased thermal stability compared to DMSO treatment, but this was not statistically significant (p=0.0646

Side Effect Profile: advantage goes to NAD+
